GlassScriptPhysician profile
Eddie Abernathy
NPI 1831178508
$1,754.29
in general payments reported to CMS, 2019-2025
18 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $45.33 · 2021: $321 · 2022: $220 · 2023: $184 · 2024: $464 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,047.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $425.89 | 2020-2025 | Rocklatan, Precision 1, Precision7 |
| Lkc Technologies, INC. | $297.32 | 2022-2024 | |
| Optos, INC. | $223.23 | 2021 | |
| Topcon Healthcare, INC. | $189.15 | 2025 | |
| Mallinckrodt Hospital Products INC. | $102.14 | 2021-2025 | Acthar |
| Allergan, INC. | $87.89 | 2019-2021 | |
| Horizon Therapeutics Plc | $80.00 | 2022 | |
| Sun Pharmaceutical Industries INC. | $74.95 | 2022-2024 | Cequa |
| Coopervision INC. | $58.43 | 2019-2025 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $55.51 | 2023-2025 | Infuse |
| Dompe US, INC. | $43.82 | 2025 | Oxervate |
| Carl Zeiss Meditec USA, INC. | $24.00 | 2025 | Forum |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.15 | 2021 | |
| Abbvie INC. | $18.80 | 2023 | Lumigan, Alphagan P, Vuity |
| Maculogix, INC. | $14.96 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $14.50 | 2019 | |
| Kala Pharmaceuticals, INC. | $12.44 | 2021 | |
| Heidelberg Engineering, INC. | $9.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eddie Abernathy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.